• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症卒中患者中,房颤预示着静脉注射组织纤溶酶原激活剂后功能恢复良好。

Atrial fibrillation predicts good functional outcome following intravenous tissue plasminogen activator in patients with severe stroke.

作者信息

Sung Sheng-Feng, Chen Yu-Wei, Tseng Mei-Chiun, Ong Cheung-Ter, Lin Huey-Juan

机构信息

Division of Neurology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.

出版信息

Clin Neurol Neurosurg. 2013 Jul;115(7):892-5. doi: 10.1016/j.clineuro.2012.08.034. Epub 2012 Sep 16.

DOI:10.1016/j.clineuro.2012.08.034
PMID:22989780
Abstract

OBJECTIVE

Atrial fibrillation (AF) is associated with poor outcome after intravenous thrombolysis probably due to greater pretreatment stroke severity. We conducted this retrospective study to determine whether AF is an independent predictor for clinical outcome in patients stratified by initial stroke severity.

METHODS

A total of 143 acute ischemic stroke patients who received intravenous thrombolysis within 3h after onset were enrolled. The patients were categorized according to the baseline stroke severity by National Institute of Health Stroke Scale (NIHSS) score (≤10 vs. >10) and the presence of AF or not. Favorable 90-day outcome was defined as a modified Rankin Scale (mRS) score<2.

RESULTS

Among the 100 patients with severe stroke (NIHSS>10), those with AF (n=52) had a higher proportion of favorable 90-day outcome than those without AF (31% vs. 8%, P=0.005). After adjustment for age, baseline glucose level, and onset to treatment time, the difference remained significant (odds ratio 5.80, 95% confidence interval 1.63-20.68). In patients with mild stroke (NIHSS≤10), no difference in clinical outcome was found between AF (n=20) and non-AF (n=23) groups.

CONCLUSION

Presence of AF was associated with favorable 90-day outcome following intravenous thrombolysis in patients with severe stroke at baseline, while the association did not exist in patients with mild stroke.

摘要

目的

心房颤动(AF)与静脉溶栓治疗后预后不良相关,可能是由于溶栓前卒中严重程度更高。我们进行了这项回顾性研究,以确定在根据初始卒中严重程度分层的患者中,AF是否是临床预后的独立预测因素。

方法

共纳入143例急性缺血性卒中患者,这些患者在发病后3小时内接受了静脉溶栓治疗。根据美国国立卫生研究院卒中量表(NIHSS)评分(≤10分与>10分)以及是否存在AF对患者进行分类。90天良好预后定义为改良Rankin量表(mRS)评分<2分。

结果

在100例重度卒中患者(NIHSS>10)中,合并AF的患者(n=52)90天良好预后的比例高于未合并AF的患者(31%对8%,P=0.005)。在调整年龄、基线血糖水平和发病至治疗时间后,差异仍然显著(比值比5.80,95%置信区间1.63-20.68)。在轻度卒中患者(NIHSS≤10)中,AF组(n=20)和非AF组(n=23)的临床预后无差异。

结论

基线时为重度卒中的患者,AF的存在与静脉溶栓治疗后90天良好预后相关,而轻度卒中患者不存在这种相关性。

相似文献

1
Atrial fibrillation predicts good functional outcome following intravenous tissue plasminogen activator in patients with severe stroke.在重症卒中患者中,房颤预示着静脉注射组织纤溶酶原激活剂后功能恢复良好。
Clin Neurol Neurosurg. 2013 Jul;115(7):892-5. doi: 10.1016/j.clineuro.2012.08.034. Epub 2012 Sep 16.
2
Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis.慢性心房颤动与静脉溶栓治疗后卒中患者不良预后之间的关系。
Arch Neurol. 2011 Nov;68(11):1454-8. doi: 10.1001/archneurol.2011.248.
3
Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator.影响静脉重组组织型纤溶酶原激活剂治疗急性缺血性脑卒中临床结局的因素。
Chin Med J (Engl). 2013;126(24):4685-90.
4
IV t-PA therapy in acute stroke patients with atrial fibrillation.急性房颤卒中患者的静脉注射组织型纤溶酶原激活剂治疗
J Neurol Sci. 2009 Jan 15;276(1-2):6-8. doi: 10.1016/j.jns.2008.10.018. Epub 2008 Nov 17.
5
Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.灌注 CT 引导下超 4.5 小时急性缺血性脑卒中静脉溶栓治疗:一项病例对照研究。
Cerebrovasc Dis. 2012;34(1):31-7. doi: 10.1159/000338778. Epub 2012 Jun 29.
6
Effect of intravenous thrombolysis on stroke associated with atrial fibrillation.静脉溶栓治疗对心房颤动相关性卒中的影响。
J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2199-2205. doi: 10.1016/j.jstrokecerebrovasdis.2014.04.035. Epub 2014 Jul 10.
7
Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.49例接受静脉注射组织纤溶酶原激活剂治疗的中风患者中,预处理MRI参数对临床结局、再通及梗死灶大小的影响
J Neurol Sci. 2004 Oct 15;225(1-2):3-9. doi: 10.1016/j.jns.2004.05.020.
8
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.中风前 CHADS2 和 CHA2DS2-VASc 评分可用于分层伴有和不伴有心房颤动的患者三个月结局。
Cerebrovasc Dis. 2013;36(4):273-80. doi: 10.1159/000353670. Epub 2013 Oct 16.
9
Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation.心房颤动缺血性卒中患者溶栓结局的相关因素
Neurosci Bull. 2016 Apr;32(2):145-52. doi: 10.1007/s12264-016-0019-8. Epub 2016 Mar 7.
10
Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.基于国立卫生研究院卒中量表评分的早期神经功能改善可预测接受静脉重组组织型纤溶酶原激活剂治疗后 30 分钟内的良好预后。
J Stroke Cerebrovasc Dis. 2014 Jan;23(1):69-74. doi: 10.1016/j.jstrokecerebrovasdis.2012.09.013. Epub 2012 Nov 16.

引用本文的文献

1
Relationship between enteral nutrition timing and 28-day mortality in critically ill stroke patients in the MIMIC-IV database.MIMIC-IV数据库中重症卒中患者肠内营养时机与28天死亡率的关系。
Front Neurol. 2024 Aug 6;15:1411906. doi: 10.3389/fneur.2024.1411906. eCollection 2024.
2
Diagnosis and Management of Atrial Fibrillation in Acute Ischemic Stroke in the Setting of Reperfusion Therapy: Insights and Strategies for Optimized Care.再灌注治疗背景下急性缺血性卒中合并心房颤动的诊断与管理:优化治疗的见解与策略
J Cardiovasc Dev Dis. 2023 Nov 12;10(11):458. doi: 10.3390/jcdd10110458.
3
Atrial Fibrillation and Reperfusion Therapy in Acute Ischaemic Stroke Patients: Prevalence and Outcomes-A Comprehensive Systematic Review and Meta-Analysis.
急性缺血性卒中患者的心房颤动与再灌注治疗:患病率与结局——一项全面的系统评价和荟萃分析
Neurol Int. 2023 Aug 25;15(3):1014-1043. doi: 10.3390/neurolint15030065.
4
Baseline brain imaging signs in patients with ischaemic stroke by the presence of atrial fibrillation: the ENCHANTED trial.伴有心房颤动的缺血性脑卒中患者的基线脑部影像学征象:ENCHANTED 试验。
J Neurol. 2023 May;270(5):2567-2575. doi: 10.1007/s00415-023-11580-x. Epub 2023 Mar 20.
5
Liver fibrosis-4 score predicts outcome of patients with ischemic stroke undergoing intravenous thrombolysis.肝脏纤维化-4评分可预测接受静脉溶栓治疗的缺血性脑卒中患者的预后。
Front Neurol. 2023 Feb 24;14:1103063. doi: 10.3389/fneur.2023.1103063. eCollection 2023.
6
The prognostic significance of large vessel occlusion in stroke patients treated by intravenous thrombolysis.静脉溶栓治疗的卒中患者大血管闭塞的预后意义。
Pol J Radiol. 2021 Jun 11;86:e344-e352. doi: 10.5114/pjr.2021.107065. eCollection 2021.
7
Efficacy and safety of thrombolysis for acute ischemic stroke with atrial fibrillation: a meta-analysis.溶栓治疗伴心房颤动的急性缺血性脑卒中的疗效和安全性:一项荟萃分析。
BMC Neurol. 2021 Feb 11;21(1):66. doi: 10.1186/s12883-021-02095-x.
8
Similar thrombolysis outcomes in acute stroke patients with and without atrial fibrillation if pre-stroke CHA2DS2-VASc score is low: A retrospective study.如果卒中前CHA2DS2-VASc评分较低,急性卒中伴或不伴心房颤动患者的溶栓结局相似:一项回顾性研究。
Medicine (Baltimore). 2020 Jan;99(2):e18680. doi: 10.1097/MD.0000000000018680.
9
Optimizing early enteral nutrition in severe stroke (OPENS): protocol for a multicentre randomized controlled trial.优化重症卒中早期肠内营养(OPENS):一项多中心随机对照试验方案
BMC Neurol. 2019 Feb 12;19(1):24. doi: 10.1186/s12883-019-1253-2.
10
Controlling Hypertension After Severe Cerebrovascular Event (CHASE): study protocol for a randomized controlled trial.重度脑血管事件后控制高血压(CHASE):一项随机对照试验的研究方案
Trials. 2018 Feb 21;19(1):130. doi: 10.1186/s13063-018-2530-x.